$ORKA Cashflow Statement | Understand Stock

$ORKA

$95.97 +$0.16 (0.17%) Close

$ORKA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 11 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Depreciation
Amortization of right-of-use asset - operating
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense
Loss from disposal of property and equipment
Net accretion of premiums and discounts on marketable securities
Non-cash interest expense
Non-cash lease expense
Depreciation expense

Changes in operating assets and liabilities:
Other current assets
Prepaid expenses and other current assets
Other non-current assets
Accrued compensation and employee benefits
Accounts payable
Accrued expenses and other current liabilities
Operating lease liability
Related party accounts payable and other current liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchases of property and equipment
Purchases of marketable securities
Proceeds from maturities of marketable securities
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of Pre-Merger Oruka Series A Preferred Stock, net of issuance costs paid
Proceeds from issuance of notes payable to related party, net of issuance costs paid
Proceeds from the Pre-Closing Financing, net
Proceeds from the PIPE Financing, net
Proceeds from the PIPE Financings, net
Cash acquired in connection with the reverse recapitalization
Proceeds from issuance of common stock upon exercise of stock options and employee warrants and purchases under employee stock purchase plan
Common stock offering costs
Net cash provided by financing activities
Net increase in cash and cash equivalents

Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures of non-cash operating and financing activities:
Operating lease liability arising from obtaining operating right-of-use asset
Assets acquired in connection with the reverse recapitalization
Other liabilities assumed in connection with the reverse recapitalization
Non-cash accrued interest on convertible note converted to common stock
Non-cash exchange of Pre-Merger Oruka Series A preferred stock for Series B convertible preferred stock
Non-cash exchange of Pre-Merger Oruka Series A Preferred Stock for Company Series B Convertible Preferred Stock
Conversion of Series A non-voting convertible preferred stock to common stock
Reclassification of the Paruka warrant from liability to equity

Comments